[en] A large body of work has been devoted to tumor necrosis factor alpha or interleukin-1 beta (IL-1 beta) signaling leading to the activation of the transcription factor nuclear factor-kappa B (NF-kappa B) in various cell types. Several studies have indicated that NF-kappa B activation depends strictly on the production of reactive oxygen intermediates. In this report, we first demonstrated that IL-1 beta is a potent activator of NF-kappa B in various epithelial transformed cell lines (OVCAR-3, SKOV-3, MCF7 A/Z). In these cells, IL-1 beta rapidly induces NF-kappa B through a complete degradation of I kappa B-alpha, while H2O2 activates NF-kappa B with slower kinetics through a partial degradation of I kappa B-alpha, p100 and p105. We showed that IL-1 beta-mediated induction of NF-kappa B in OVCAR-3 and in other epithelial cell lines does not proceed through the production of reactive oxygen intermediates, while the same cytokine activates NF-kappa B in lymphoid cells through the intracellular generation of H2O2. Our study demonstrated that several signaling pathways lead to the activation of NF-kappa B, following IL-1 beta treatment in different cell types.
Baeuerle, P.A., Henkel, T., Function and activation of NF-κB in the immune system (1994) Annu. Rev. Immunol., 12, pp. 141-179
Siebenlist, U., Franzoso, G., Brown, K., Structure, regulation, and function of NF-κB (1994) Annu. Rev. Biol., 10, pp. 405-455
Miyamoto, S., Verma, I.M., Rel/NF-κB/lKB story (1995) Adv. Cancer Res., 66, pp. 255-292
Beg, A.A., Baldwin, A.S., The IκB proteins: Multifunctional regulators of Rel/NF-κB transcription factors (1993) Genes & Dev., 7, pp. 2064-2070
Haskill, S., Beg, A.A., Tompkins, S.M., Morris, J.S., Yurochko, A.D., Sampson-Johannes, A., Mondal, K., Baldwin, A.S.J., Characteriaation of an immediate-early gene induced in adherent monocyles that encodes I kappa B-like activity (1991) Cell, 65, pp. 1281-1289
Mercurio, F., DiDonato, J.A., Rosette, C., Karin, M., p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction (1993) Genes & Dev., 7, pp. 705-718
Rice, N.R., MacKichan, M.L., Israël, A., The precursor of NF-κB p50 has IκB-like functions (1992) Cell, 71, pp. 243-253
Thompson, J.E., Phillips, R.J., Erdjument-Bromage, H., Tempst, P., Ghosh, S., Iκ-B-β regulates the persistent response in a biphasic activation of NF-κB (1995) Cell, 80, pp. 573-582
Bours, V., Franzoso, G., Azarenko, V., Park, S., Kanno, T., Brown, K., Siebenlist, U., The oncoprotein Bcl-3 directly transactivates through κB motifs via association with DNA-binding p50B homodimers (1993) Cell, 72, pp. 729-739
Franzoso, G., Bours, V., Park, S., Tomita-Yumaguchi, M., Kelly, K., Siebenlist, U., The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-κB-mediated inhibition (1992) Nature, 359, pp. 339-342
Nolan, G.P., Fujita, T., Bhatia, K., Huppi, C., Liou, H.-C., Scott, M.L., Baltimore, D., The bcl-3 proto-oncogene encodes a nuclear IκB-like molecule that preferentially interacts with NF-κB p50 and p52 in a phosphorylation-dependent manner (1993) Mol. Cell. Biol., 13, pp. 3557-3566
Ohno, H., Takimoto, G., McKeithan, T.W., The candidate proto-oncogene bcl-3 is related to genes implicated in cell lineage determination and cell cycle control (1990) Cell, 60, pp. 991-997
Anisowicz, A., Messineo, M., Lee, S.W., Sager, R., An NF-kappa B-like transcription factor mediates IL,-1/TNF-alpha induction of gro in human fibroblasts (1991) J. Immunol., 147, pp. 250-257
Duh, E.J., Maury, W.J., Folks, T.M., Fauci, A.S., Rabson, A.B., Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat (1989) Proc. Natl Acad. Sci USA, 86, pp. 5974-5978
Lowenthal, J.W., Ballard, D.W., Bogerd, H., Böhnlein, H., Greene, W.C., Tumor necrosis factor-α activation of the IL-2 receptor-a involves the induction of kB-specifie DNA binding proteins (1989) J. Immunol., 142, pp. 3121-3128
Osborn, L., Kunkel, S., Nabel, G.J., Tumor necrosis factor α and Interleukine 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB (1989) Proc. Natl Acad. Sci. USA, 86, pp. 2336-2340
Beg, A.A., Finco, T.S., Nantermet, P.V., Baldwin, A.S.J., Tumor necrosis factor and interleukine-1 lead to phosphorylation and loss of IκBa: A mechanism for NF-κB activation (1993) Mol. Cell Biol., 13, pp. 3301-3310
Brown, K., Park, S., Kanno, T., Franzoso, G., Sibenlist, U., Mutual regulation of the transcriptional activator NF-κB and its inhibitor, IκB-α (1993) Proc. Natl Acad. Sci. USA, 90, pp. 2532-2536
Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., Siebenlist, U., Control of IκB-α proteolysis by site-specific, signalinduced phosphorylation (1995) Science, 267, pp. 1485-1488
Palombella, V.J., Rando, O.J., Goldberg, A.L., Maniatis, T., The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB (1994) Cell, 78, pp. 77-85
Traenckner, E.B.-M., Wilk, S., Baeuerle, P.A., A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α that is still bound to NF-κB (1994) EMBO J., 13, pp. 5433-5441
Traenckner, E.B.-M., Pahl, H.L., Henkel, T., Schmidt, K.N., Wilk, S., Baeuerle, P.A., Phosphorylation of IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli (1995) EMBO J., 14, pp. 2876-2883
Schreck, R., Rieber, P., Baeuerle, P.A., Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 (1991) EMBO J., 10, pp. 2247-2258
Schreck, R., Meier, B., Mannel, D.N., Droge, W., Baeuerle, P.A., Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells (1992) J. Exp. Med., 175, pp. 1181-1194
Brennan, P., O'Neill, L.A.J., Effects of oxidants and anti-oxidants on nuclear factor κB activation in three different cell lines: Evidence against a universal hypothesis involving oxygen radicals (1995) Biochim. Biophys. Acta, 1260, pp. 167-175
Dejardin, E., Bonizzi, G., Bellahcène, A., Castronovo, V., Merville, M.-P., Bours, V., Highly-expressed p100/p52 (NFKB2) sequesters other NF-κB-related proteins in the cytoplasm of human breast cancer cells (1995) Oncogene, 11, pp. 1835-1841
Royall, J.A., Ischiropoulos, H., Evaluation of 2′,7′-dihydrorhodamine 123 as fluorescent probes for intracelluar H2O2 in cultured endothelial cells (1993) Arch. Biochem. Biophys., 302, pp. 348-355
Bours, V., Dejardin, E., Goujon-Letawe, F., Merville, M.-P., Castronovo, V., The NF-κB transcription factor and cancer: High expression of NF-κB and IκB-related proteins in tumor cell lines (1994) Biochem. Pharmacol., 47, pp. 145-149
Kilian, P.L., Kaffka, K.L., Biondi, D.A., Lipman, J.M., Benjamin, W.R., Feldman, D., Campen, C.A., Antiproliferative effect of interleukine-1 on human ovarian carcinoma cell line (NIH: OVCAR-3) (1991) Cancer Res., 51, pp. 1823-1828
Naumann, M., Scheidereit, C., Activation of NF-κB in vivo is regulated by multiple phosphorylations (1994) EMBO J., 13, pp. 4597-4607
Ballou, L.R., Chao, C.P., Holness, M.A., Barker, S.C., Ragshow, R., Interleukin-1-mediated PGE2 production and sphingomyelin metabolism (1992) J. Biol. Chem., 267, pp. 20044-20050
Kolesnick, R., Golde, D.W., The sphingomyelin pathway in tumor necrosis factor and Interleukine-1 signaling (1994) Cell, 77, pp. 325-328
Sandstrom, P.A., Roberts, B., Folks, T.M., Buttke, T.M., HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis (1993) AIDS Res. Hum. Retrov., 9, pp. 1107-1113
Ray, K.P., Kennard, N., Interleukin-1 induces a nuclear form of transcription factor NF-κB in human lung epithelial cells (1993) Agents Actions, 38, pp. C61-C63
Los, M., Schenk, H., Hexel, K., Baeuerle, P.A., Dröge, W., Schulze-Osthoff, K., IL-2 gene expression and NF-κB activation through CD28 requires reactive oxygen production by 5-lipoxygenase (1995) EMBO J., 14, pp. 3731-3740
Schütze, S., Potthoff, K., Machleidt, T., Berkovic, D., Wiegmann, K., Krönke, M., TNF activates NF-κB by phosphatidylcholine-specific phopholipase C-induced 'acidic' sphingomyelin breakdown (1992) Cell, 71, pp. 765-776
Wiegmann, K., Schütze, S., Machleidt, T., Witte, D., Krönke, M., Functional dichotomy of neutral and acidic sphingomy-elinases in tumor necrosis factor signaling (1994) Cell, 78, pp. 1005-1015
Stylianou, E., O'Neill, L.A.J., Rawlinson, L., Edbrooker, M.R., Woo, P., Saklatvala, J., Interleukin 1 induces NF-κB through its type I but not its type II receptor in lyphocytes (1992) J. Biol. Chem., 267, pp. 15836-15841
Moynagh, P.N., Williams, D.C., O'Neill, L.A.J., Activation of NF-κB and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1 (1994) J. Immunol., 153, pp. 2681-2690
Oppenheim, J.J., Kovacs, E.J., Matsushima, K., Durum, S.K., There is more than one interleukin 1 (1986) Immunol. Today, 7, pp. 45-56
Kang, S.M., Tran, A.C., Grilli, M., Lenardo, M.J., NF-kappa B subunit regulation in nontransformed CD4+ T lymphocytes (1992) Science, 256, pp. 1452-1456
Kunsch, C., Ruben, S.M., Rosen, C.A., Selection of optimal kB/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptionnal activation (1992) Mol. Cell. Biol., 12, pp. 4412-4421
Miyamoto, S., Schmitt, M.J., Verma, I.M., Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation (1994) Proc. Natl Acad. Sci. 91 USA, pp. 5056-5060